William Schmalz
Internal Medicine · Bloomington, INNPI 1336255900
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 57 manufacturers reported payments, led by Amarin Pharma, Inc. at 46.5% of the total. Reporting peaked in 2019 at $19,393 and has fallen 99.9% since, to $21 in 2025. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,201 payments — averaging $30.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$17K
- AbbVie$6K
- Amgen$2K
- AstraZeneca$2K
- Novartis$1K
- GSK$1K
- plus $8K from 51 others
What the payments were for
- Speaking & faculty fees$17,79048%
- Travel & lodging$2,2896%
- Food & beverage$16,64845%
- Education$2121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,939 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 12 | $3,623 |
| Mirtazapine | 13 | $650 |
| Amiodarone Hcl | 12 | $394 |
| Sertraline Hcl | 12 | $258 |
| Atorvastatin Calcium | 13 | $247 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta | $79 | $3,62312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Bloomington
- Abhinav SinghGreenwood$733K
- Girish KunapareddyTerre Haute$329K
- Raj VuppalanchiIndianapolis$279K
- Joseph Arulandula Porte$251K
- Napoleon MamintaIndianapolis$116K
- Jennifer PaisleyLawrenceburg$112K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
- Emily FrankLebanon$100K
- David IloFort Wayne$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.